354
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Co-existent B-cell and plasma cell neoplasms: a case series providing novel clinical insight

, , , &
Pages 557-562 | Received 25 Apr 2015, Accepted 02 Jun 2015, Published online: 07 Jul 2015

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5–29.
  • Desport E, Bridoux F, Sirac C, et al. Al amyloidosis. Orphanet J Rare Dis 2012;7:54.
  • Smith A, Howell D, Patmore R, et al. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 2011;105:1684–1692.
  • Rawstron AC, Bennett FL, O’Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359:575–83.
  • Swerdlow SH, Campo E, Harris NL, et al.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
  • Kourelis TV, Gertz M, Zent C, et al. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2013;88:375–378.
  • Telio D, Bailey D, Chen C, et al. Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature. Am J Hematol 2010;85:805–808.
  • Sanchorawala V, Blanchard E, Seldin DC, et al. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol 2006;81:692–695.
  • Alley CL, Wang E, Dunphy CH, et al. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature. Arch Pathol Lab Med 2013;137:503–517.
  • Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467–1473.
  • Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005;79:319–328.
  • Wei Q, Sebastian S, Papavassiliou P, et al. Metachronous/concomitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions. Hum Pathol 2014;45:2063–2076.
  • Pantic M, Schroettner P, Pfeifer D, et al. Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma. Leukemia 2010;24:885–890.
  • Kaufmann H, Ackermann J, Nosslinger T, et al. Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma—a report on two cases. Ann Hematol 2001;80:474–478.
  • Chang H, Wechalekar A, Li L, et al. Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin. Cancer Genet Cytogenet 2004;148:44–48.
  • Patriarca F, Gaidano G, Capello D, et al. Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation. Haematologica 2000;85:982–985.
  • Kriangkum J, Motz SN, Debes Marun CS, et al. Frequent occurrence of highly expanded but unrelated B-cell clones in patients with multiple myeloma. PLoS One 2013;8:e64927.
  • Fermand JP, James JM, Herait P, et al. Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone. Blood 1985;66:291–293.
  • Saltman DL, Ross JA, Banks RE, et al. Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood 1989;74:2062–2065.
  • Leung-Hagesteijn C, Erdmann N, Cheung G, et al. Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma. Cancer Cell 2013;24: 289–304.
  • Robak T, Huang H, Jin J, et al. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. N Engl J Med 2015;372: 944–953.
  • Linder J, Silberman HR, Croker BP. Amyloidosis complicating hairy cell leukemia. Am J Clin Pathol 1982;78:864–867.
  • Benson MD, Kramer G, Abonour R. Hairy cell leukemia and light chain (AL) amyloidosis: a case report. Amyloid 2011;18(Suppl. 1): 101–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.